What Happens When You Stop Ozempic? The Skills That Remain When the Shots Don't

GLP-1 medications like Ozempic and Wegovy have changed what's possible for a lot of people — the weight loss is real, and for many it's life-changing. But there's a question that matters just as much as how well they work, and it gets far less attention: what happens when you stop? Because most people do stop eventually, and the honest answer shapes how you should use the time you're on them.

This isn't an argument against the medication — that's a conversation for you and your doctor, and nothing here is medical advice. It's about the one part a prescription can't do for you, and why it's the part worth building now.

The two-thirds problem

The clearest data comes from the trial that put semaglutide on the map. In the STEP 1 extension, participants lost an average of 17.3 percent of their body weight on the medication — a genuinely large result. Then researchers followed what happened after they came off it. Within a year of stopping, they had regained roughly two-thirds of the weight they'd lost, and the improvements in things like blood pressure and blood sugar drifted back toward where they started.

It's not unique to semaglutide. In the SURMOUNT-4 trial of tirzepatide, people who switched from the drug to a placebo regained around 14 percent of their body weight on average, and 82 percent of them put back on more than a quarter of what they had lost. The pattern is consistent across the class: the medication holds weight down while you take it, and a large share returns when you stop.

And stopping is the norm, not the exception

Here's the part that makes this everyone's question, not a niche one. Staying on these medications indefinitely is far less common than you'd think. A large analysis of more than 125,000 adults found that roughly 54 percent had stopped within a year, and about 72 percent within two. Other researchers put the first-year discontinuation rate somewhere between 50 and 75 percent.

And the reasons usually aren't "I hit my goal." They're cost, insurance changes, supply issues, and side effects. In other words, a lot of people come off these drugs before they intended to — which means the question of what happens next isn't hypothetical or distant. For most people who start, it arrives.

But regain isn't inevitable — and that's the whole point

If the story ended there it would just be discouraging. It doesn't. The same research that documents the regain also shows a group of people who don't follow that curve — and what separates them is learnable.

A 2026 real-world study from the Cleveland Clinic tracked obesity patients in the year after they stopped their medication and found that around 45 percent kept losing weight or held steady. The difference between that group and the group that regained wasn't luck or genetics. It was lifestyle intervention and continued self-management — the people who maintained had built habits during their time on the drug and kept them going after.

That lines up exactly with what we know from people who've maintained large weight losses the old-fashioned way. In the research on long-term maintainers, the single behavior that most reliably separates those who keep weight off from those who regain it is sustained self-monitoring — keeping loose, ongoing track of what they eat, so a small drift gets caught before it becomes a big one. (We went deep on that evidence in how people actually keep weight off.)

The medication buys you something valuable — use it

Here's the reframe worth sitting with. A GLP-1 doesn't teach you how to eat. It quiets your appetite so that, for a while, eating less feels almost effortless. That's genuinely useful — but it's temporary by design, and the effortlessness can hide the fact that no new skills are being built underneath it.

So the smartest way to use the window — while appetite is quiet and the pressure is off — is to actually learn your own eating. What your normal portions look like. Where your protein lands. Which meals anchor your week and which days tend to drift. If you build that awareness now, it's still there when the prescription isn't. If you don't, you come off the medication with the same blind spots you had going in, and the two-thirds curve is waiting.

Where Rekkon fits

This is the part a medication can't do, and it's exactly what Rekkon is built for. Instead of a food diary you'll abandon in a fortnight, you just say what you ate — "two eggs on sourdough with avocado" — and it works out the calories and macros and quietly learns your patterns. The friction that normally kills self-monitoring is gone, which matters enormously here: the habit only protects you if you can actually sustain it past the prescription.

A few things that make it a natural companion during and after a GLP-1:

• It builds the awareness while it's easy. Logging when your appetite is suppressed and portions are small is about as low-effort as tracking ever gets — the ideal time to learn your own eating.
• It watches your protein. Preserving muscle matters a lot on and after these medications, and protein is the thing people most often fall short on. Rekkon surfaces it so you can see where you stand.
• It catches the drift. After you stop, it's the early-warning signal — the small regain spotted in week two instead of month six, while it's still easy to correct.

To be clear about the lane: Rekkon isn't a medication tracker and it isn't a substitute for your doctor or a dietitian. It's the food-awareness companion for the part the prescription was never going to handle — alongside your treatment, not instead of it.

The bottom line

GLP-1 medications are a powerful tool, and using one is a decision to make with your doctor. But the evidence is consistent: the weight tends to come back when the medication stops, most people do stop, and the ones who hold onto their progress are the ones who built durable eating habits along the way. The shots do the appetite work. The skills are yours to keep — if you build them. That's the part worth starting now, while it's easy.

This article is general information, not medical advice, and doesn't replace guidance from your doctor. Never start, stop, or change a prescription medication based on something you read online — decisions about GLP-1 medications should be made with your prescribing clinician. If you have a history of disordered eating, talk to a professional before taking on any food-tracking habit.